Lv4
564 积分 2025-02-10 加入
Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation
2天前
已完结
Why Early, Large-scale Weight Loss Is the Future of Type 2 Diabetes Care
2天前
已关闭
The association between glycaemic control, normal weight and long‐term macrovascular outcomes in people with type 2 diabetes in China: A retrospective study
2天前
已完结
GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes
6天前
已完结
Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): a 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trial
6天前
已完结
Mazdutide versus placebo in Chinese adults with type 2 diabetes
6天前
已完结
Managing early-onset type 2 diabetes in the individual and at the population level
9天前
已完结
Understanding the drivers and consequences of early-onset type 2 diabetes
9天前
已完结
Early-onset type 2 diabetes: the next major diabetes transition
9天前
已完结
Effects of glucose-lowering drugs on cardiovascular outcomes in patients with type 2 diabetes: an update
14天前
已完结
皖公网安备34019202002308
